<?xml version="1.0" encoding="UTF-8"?>
<p>Whilst the 
 <italic>in vitro</italic> studies showed promising results for MPA against MERS, the 
 <italic>in vivo</italic> studies suggest that its use is likely to cause more harm than benefit and hence is not likely to be useful against coronavirus infections. The clinical studies are too small to confirm or deny any beneficial use for MERS-CoV patients.
</p>
